SAC Capital Advisors LP, the $14 billion hedge fund run by Steven A. Cohen that's being investigated by regulators for insider trading, said it's investment in Cougar Biotechnology Inc. before the company was bought by Johnson & Johnson (JNJ) in 2009 was "perfectly reasonable" and based on publicly available information.